載入...

Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy

<p><strong>Background.</strong> Therapy for metastatic castration-resistant prostate cancer (CRPC) is a serious problem that requires significant public health care expenditures.</p><p><strong>Objective</strong>: to evaluate the cost-effectiveness of abirate...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: A. V. Rudakova, D. O. Meshkov, S. V. Mishugin
格式: Artigo
語言:Russo
出版: ABV-press 2014-11-01
叢編:Onkourologiâ
主題:
在線閱讀:http://oncourology.abvpress.ru/index.php/oncur/article/view/383
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!